Armand Girard - Net Worth and Insider Trading
Armand Girard Net Worth
The estimated net worth of Armand Girard is at least $11,594 dollars as of 2024-11-13. Armand Girard is the SVP, Chief Business Officer of GlycoMimetics Inc and owns about 29,161 shares of GlycoMimetics Inc (GLYC) stock worth over $11,594. Details can be seen in Armand Girard's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Armand Girard has not made any transactions after 2022-11-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Armand Girard
Armand Girard Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Armand Girard owns 1 companies in total, including GlycoMimetics Inc (GLYC) .
Click here to see the complete history of Armand Girard’s form 4 insider trades.
Insider Ownership Summary of Armand Girard
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| GLYC | GlycoMimetics Inc | 2022-11-11 | SVP & Strategy & Corporate Dev |
Armand Girard Latest Holdings Summary
Armand Girard currently owns a total of 1 stock. Armand Girard owns 29,161 shares of GlycoMimetics Inc (GLYC) as of November 11, 2022, with a value of $11,594.
Latest Holdings of Armand Girard
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| GLYC | GlycoMimetics Inc | 2022-11-11 | 29,161 | 0.40 | 11,594 |
Holding Weightings of Armand Girard
Armand Girard Form 4 Trading Tracker
According to the SEC Form 4 filings, Armand Girard has made a total of 2 transactions in GlycoMimetics Inc (GLYC) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in GlycoMimetics Inc is the acquisition of 6,500 shares on November 11, 2022, which cost Armand Girard around $6,825.
Insider Trading History of Armand Girard
- 1
Armand Girard Trading Performance
GuruFocus tracks the stock performance after each of Armand Girard's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Armand Girard is 180.65%. GuruFocus also compares Armand Girard's trading performance to market benchmark return within the same time period. The performance of stocks bought by Armand Girard within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Armand Girard's insider trading performs compared to the benchmark.
Performance of Armand Girard
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 66.94 | | | | | |
| Relative Return to S&P 500(%) | 68.41 | | | | | |
Armand Girard Ownership Network
Ownership Network List of Armand Girard
Ownership Network Relation of Armand Girard
Armand Girard Owned Company Details
What does GlycoMimetics Inc do?
Who are the key executives at GlycoMimetics Inc?
Armand Girard is the SVP & Strategy & Corporate Dev of GlycoMimetics Inc. Other key executives at GlycoMimetics Inc include 10 percent owner Invus Public Equities, L.p. , Chief Medical Officer Edwin Rock , and CFO Brian M. Hahn .
GlycoMimetics Inc (GLYC) Insider Trades Summary
Over the past 18 months, Armand Girard made no insider transaction in GlycoMimetics Inc (GLYC). Other recent insider transactions involving GlycoMimetics Inc (GLYC) include a net sale of 2,271,499 shares made by Invus Public Equities, L.p. , a net purchase of 370,403 shares made by Edwin Rock , and a net purchase of 13,800 shares made by Brian M. Hahn .
In summary, during the past 3 months, insiders sold 0 shares of GlycoMimetics Inc (GLYC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 2,275,199 shares of GlycoMimetics Inc (GLYC) were sold and 387,903 shares were bought by its insiders, resulting in a net sale of 1,887,296 shares.
GlycoMimetics Inc (GLYC)'s detailed insider trading history can be found in Insider Trading Tracker table.
GlycoMimetics Inc Insider Transactions
Armand Girard Mailing Address
Above is the net worth, insider trading, and ownership report for Armand Girard. You might contact Armand Girard via mailing address: C/o Glycomimetics, Inc., 9708 Medical Center Drive, Rockville Md 20850.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
